Safety of multitargeted therapy using 2 biologics or 1 biologic and 1 JAKi in refractory paediatric inflammatory disorders: a retrospective multicentric cohort

Annals of the Rheumatic Diseases 2026

View at publisher
Authors: Clément Triaille, Giulia Jannone, Cécile Boulanger, Jean Jacques De Bruycker, Lien De Somer, Joke Dehoorne, Colette Deslandres, Martha Dirks, Véronique Groleau, Kelly Grzywacz, Elie Haddad, Ugur Halac
+9 more Prévost Jantchou, Raphaël Kraus, Roxane Labrosse, Marie‐Paule Morin, Thomas Renson, Isabelle Scheers, Fabien Touzot, Laurence Chapuy, Julie Barsalou
DOI: 10.1016/j.ard.2026.01.007
Cited by: 1
References: 5

Fields of Study & Subjects

Autoimmune and Inflammatory Disorders Research Vasculitis and related conditions Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Annals of the Rheumatic Diseases
Publisher
Elsevier BV
Volume
85
Issue
6
Pages
1191–1193
Publication date
11 February 2026
Language
EN